Skip to content
DataLookout
Menu

AppDate-YouNCT05286034

Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 11 words Show 7 more changesShow less
    • Primary endpoints: details revised at 2 of 3 entries
    • Trial completed
    • Final enrollment: 5125 participants (planned 3000)
    • Primary completion date changed from estimate of Jul 31, 2026 to Nov 30, 2025
    • Study completion date changed from estimate of Aug 18, 2026 to Apr 18, 2026
    • Site details revised
    • Publications: 1 to 2
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 15, 2025 to Nov 3, 2025
    • Site details revised
    v4
  3. Notable Primary completion date: Apr 30, 2025 to Jul 31, 2026v3 Show 5 more changesShow less
    • Start date: Jun 1, 2024 to Sep 15, 2025
    • Eligibility criteria shortened, about 3 words
    • Enrollment target: 4000 to 3000
    • Study completion date: Dec 31, 2025 to Aug 18, 2026
    • Site contact updated
  4. Notable Start date: Jan 2, 2023 to Jun 1, 2024
    • Publications: details revised at 1 of 1 entry
    v2
  5. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

HPV self-sampling "return" rate
Timeframe: 1 year after postal mail
Proportion of HPVss-positive women "well managed"
Timeframe: 1 year after postal mail
Cost and cost-efficacy
Timeframe: Month 36 - Month 48

Arms and interventions

Intervention groupExperimental

Women randomized to this group will be sent screening reminder letters to perform HPV self-sampling test, with access to a decision aid tool tailored to those with low education levels. This tool will be available via Chatbot platforms.

Control groupNo intervention

Women randomized to this group will be sent screening reminder letters to perform HPV self-sampling test (Standard care)

Behavioral: Decision aid tailored to women with lower educational attainment,accessible via artificial intelligence-based Chatbot platforms

Sites

1 site in 1 country

  • Centre Régional de Coordination des Dépistages des Cancers-Centre d'OccitanieCarcassone, France